Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis

NCT01216891 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2016-11-03

No results posted yet for this study

Summary

This study will assess the effectiveness of an experimental treatment intervention for adolescents and adults who have experienced their first episode of psychosis during the past two years.

The DUP sub-study will collect pathways to care information that will be used to inform the development and pilot testing of strategies that aim to reduce DUP among individuals experiencing a first episode of psychosis.

Conditions

Interventions

BEHAVIORAL

Multi-element, team-oriented treatment

Participants will receive treatment and services based on their needs coordinated by a small team that is led by a clinical coordinator. Services that are available to the participants include social skills training, medication treatment to address symptoms, education and employment advising, and substance use treatment.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • University of Maryland

    collaborator OTHER
  • New York State Office of Mental Health (OMH)

    collaborator UNKNOWN
  • Maryland Department of Health and Mental Hygiene

    collaborator OTHER_GOV
  • Research Foundation for Mental Hygiene, Inc.

    lead OTHER

Principal Investigators

  • Lisa Dixon, MD · Columbia University

  • Melanie Bennett, PhD · University of Maryland

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2015-01-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01216891 on ClinicalTrials.gov